{
    "clinical_study": {
        "@rank": "35039", 
        "arm_group": [
            {
                "arm_group_label": "Ergoferon (5 ml 3 times a day)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo (5 ml 3 times a day)", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is:\n\n        -  to assess safety of the liquid dosage form of Ergoferon for treatment of acute upper\n           respiratory tract infections in adult patients.\n\n        -  to assess clinical efficiency of the liquid dosage form of Ergoferon for treatment of\n           acute upper respiratory tract infections in adult patients."
        }, 
        "brief_title": "Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Upper Respiratory Tract Infections", 
        "condition_browse": {
            "mesh_term": "Respiratory Tract Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients of both sexes aged from 18 to 60 inclusively.\n\n          2. Patients who consulted a doctor during the increase of seasonal incidence within 24\n             hours after the onset of acute upper respiratory tract infection.\n\n          3. Body temperature at least 37.8 \u00b0\u0421 at the moment of examination by the doctor.\n\n          4. Presence of two or more moderate level symptoms or three or more mild level symptoms\n             according to the CCQ scale.\n\n          5. The possibility to start therapy within 24 hours after the onset of the first\n             symptoms of acute upper respiratory tract infection.\n\n          6. Usage of contraceptive methods by the patients of both the sexes during the trial and\n             within 30 days after ending of the participation in the trial.\n\n          7. Availability of information sheet (informed consent form for taking part in the\n             clinical trial) signed by the patient.\n\n        Exclusion Criteria:\n\n          1. Suspected invasive bacterial infection or presence of severe disease requiring use of\n             antibacterial drugs (including sulfanilamides).\n\n          2. Suspected initial manifestations of diseases that have symptoms similar to ARI (other\n             infectious diseases, flu-like symptoms at the onset of systemic connective tissue\n             disorders, oncohematological and other pathologies).\n\n          3. Exacerbation or decompensation of chronic diseases affecting the patient's ability to\n             participate in a clinical trial.\n\n          4. Oncological diseases.\n\n          5. Medical history of polyvalent allergy.\n\n          6. Allergy / intolerance to any of the components of medications used in the treatment.\n\n          7. Impaired glucose tolerance, diabetes mellitus type 1 and 2.\n\n          8. Hereditary fructose intolerance (due to the presence of maltitol in the examined\n             medicine).\n\n          9. Intake of medicines listed in the section \"Prohibited concomitant treatment\" for 1\n             month prior to participation in the trial.\n\n         10. Pregnancy, breast feeding.\n\n         11. Drugs usage, alcohol usage in the amount over 2 units of alcohol per day.\n\n         12. Patients with mental disorders.\n\n         13. Patients, who from investigator's point of view will fail to comply with the\n             observation requirements of the trial or with the intake regimen of the investigated\n             medicines.\n\n         14. Participation in other clinical trials in the course of 3 months prior to inclusion\n             into the present trial.\n\n         15. Other factors, which hinder the patient's participation in the trial (for example,\n             planned trips or business trips).\n\n         16. The patient is related to the research personnel of the centre who are directly\n             involved in the trial or are the immediate family of the researcher. The immediate\n             family includes husband / wife, parents, children or brothers / sisters, regardless\n             of whether they are natural or adopted.\n\n         17. The patient works for OOO \"NPF \"Materia Medica Holding\", i.e. s/he is the company's\n             employee, temporary contract worker, and designated official responsible for carrying\n             out the research or their immediate family."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "282", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765920", 
            "org_study_id": "MMH-ER-006"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ergoferon (5 ml 3 times a day)", 
                "description": "Safety and Efficiency of liquid dosage form", 
                "intervention_name": "Ergoferon", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo (5 ml 3 times a day)", 
                "description": "Safety and Efficiency of liquid dosage form", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chelyabinsk", 
                        "country": "Russian Federation", 
                        "zip": "454091"
                    }, 
                    "name": "Non-governmental Health Care Institution \"Road Clinical Hospital at the train station Chelyabinsk of OJSC \"Russian Railways\""
                }, 
                "status": "Terminated"
            }, 
            {
                "contact": {
                    "last_name": "Rustem Khamitov, Prof"
                }, 
                "facility": {
                    "address": {
                        "city": "Kazan", 
                        "country": "Russian Federation", 
                        "zip": "420012"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"Kazan State Medical University\""
                }, 
                "investigator": {
                    "last_name": "Rustem Khamitov, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Boris Bart, Prof"
                }, 
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "117997"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"The Russian National Research Medical University named after N.I. Pirogov\""
                }, 
                "investigator": {
                    "last_name": "Boris Bart, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marina Mikhailusova, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "117997"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"The Russian National Research Medical University named after N.I. Pirogov\""
                }, 
                "investigator": {
                    "last_name": "Marina Mikhailusova, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "105064"
                    }, 
                    "name": "Federal State Budgetary Institution \"Scientific Research Institute for Vaccines and Serum named after I.I.Mechnikov\" of Russian Academy of Medical Science"
                }, 
                "status": "Completed"
            }, 
            {
                "contact": {
                    "last_name": "Elena Minina, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "129090"
                    }, 
                    "name": "Federal State Budgetary Institution \"Polyclinic \u2116 3\" of Affairs Management Department of the President of Russian Federation"
                }, 
                "investigator": {
                    "last_name": "Elena Minina, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "117630"
                    }, 
                    "name": "LLC \"Panacea Clinic\""
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Podolsk", 
                        "country": "Russian Federation", 
                        "zip": "142105"
                    }, 
                    "name": "Municipal Health Care Institution \"Podolsk city clinical hospital \u21163\""
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Smolensk", 
                        "country": "Russian Federation", 
                        "zip": "214000"
                    }, 
                    "name": "Regional State Budgetary Health Care Institution \"Policlinic \u2116 6\""
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "199034"
                    }, 
                    "name": "Federal State Budgetary Health Care Institution Policlinic \u2116 1 of the Russian Academy of Sciences"
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "199178"
                    }, 
                    "name": "St. Petersburg State Budgetary Health Care Institution \"\u0421ity Polyclinic \u2116 4\""
                }, 
                "status": "Terminated"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "195112"
                    }, 
                    "name": "St. Petersburg State Budgetary Health Care Institution \"Medical Exercises Dispensary\" of Krasnogvardeysky District"
                }, 
                "status": "Terminated"
            }, 
            {
                "contact": {
                    "last_name": "Mikhail Ilkovich, Prof"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "197022"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"St. Petersburg State Medical University named after I.P. Pavlov\""
                }, 
                "investigator": {
                    "last_name": "Mikhail Ilkovich, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "197002"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"St. Petersburg State Medical University named after I.P. Pavlov\""
                }, 
                "status": "Terminated"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "194358"
                    }, 
                    "name": "St. Petersburg State Budgetary Health Care Institution \"\u0421ity Polyclinic \u2116 117\""
                }, 
                "status": "Terminated"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Petersburg", 
                        "country": "Russian Federation", 
                        "zip": "193312"
                    }, 
                    "name": "St. Petersburg State Budgetary Health Care Institution \" Nevsky Region \u0421ity Polyclinic \u211625\""
                }, 
                "status": "Enrolling by invitation"
            }, 
            {
                "contact": {
                    "last_name": "Andrey Babkin, MD,PhD, ScD, professor"
                }, 
                "facility": {
                    "address": {
                        "city": "Voronezh", 
                        "country": "Russian Federation", 
                        "zip": "394036"
                    }, 
                    "name": "State Educational Institution of Higher Professional Education \"Voronezh State Medical Academy of N. N. Burdenko\" Ministry of Health of the Russian Federation"
                }, 
                "investigator": {
                    "last_name": "Andrey Babkin, MD, PhD, ScD, professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dmitriy Petrov, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation", 
                        "zip": "150000"
                    }, 
                    "name": "State Budgetary Educational Institution of Higher Professional Education \"Yaroslavl State Medical Academy\""
                }, 
                "investigator": {
                    "last_name": "Dmitriy Petrov, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maria Yanovskaya, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation", 
                        "zip": "150062"
                    }, 
                    "name": "State Budgetary Health Care Institution of the Yaroslavl region \"Regional Clinical Hospital\""
                }, 
                "investigator": {
                    "last_name": "Maria Yanovskaya, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adult Patients", 
        "overall_contact": {
            "email": "PutilovskiyMA@materiamedica.ru", 
            "last_name": "Mikhail Putilovskiy, MD", 
            "phone": "+74957836804", 
            "phone_ext": "302"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Average duration of fever (body temperature over 37.0 \u0421) (according to the patient's diary).", 
            "safety_issue": "No", 
            "time_frame": "7(\u00b1 1) days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765920"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Dynamics of the clinical manifestations of ARI according to the objective medical examination (summary score of the CCQ scale at first, third and seventh days of treatment)", 
            "safety_issue": "No", 
            "time_frame": "7(\u00b1 1) days"
        }, 
        "source": "Materia Medica Holding", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Materia Medica Holding", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}